Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

QTc interval screening in methadone treatment.

Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC.

Ann Intern Med. 2009 Mar 17;150(6):387-95. Epub 2009 Jan 19.

PMID:
19153406
2.

Prolonged QT interval and methadone: implications for palliative care.

Wilcock A, Beattie JM.

Curr Opin Support Palliat Care. 2009 Dec;3(4):252-7. doi: 10.1097/SPC.0b013e328332e0a4. Review.

PMID:
19797957
3.

QTc interval screening for cardiac risk in methadone treatment of opioid dependence.

Pani PP, Trogu E, Maremmani I, Pacini M.

Cochrane Database Syst Rev. 2013 Jun 20;(6):CD008939. doi: 10.1002/14651858.CD008939.pub2. Review.

PMID:
23787716
4.

Methadone and the heart: what the clinician needs to know.

George S, Moreira K, Fapohunda M.

Curr Drug Abuse Rev. 2008 Nov;1(3):297-302. Review.

PMID:
19630728
5.

Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).

Deamer RL, Wilson DR, Clark DS, Prichard JG.

J Addict Dis. 2001;20(4):7-14. Review.

PMID:
11760927
6.

Methadone and torsade de pointes: case report and review of the literature.

Iskandar SB, Abi-Saleh BS, Mechleb BK, Fahrig SA.

Tenn Med. 2007 Feb;100(2):35-7, 42. Review.

PMID:
17378505
7.

Methadone-associated Q-T interval prolongation and torsades de pointes.

Stringer J, Welsh C, Tommasello A.

Am J Health Syst Pharm. 2009 May 1;66(9):825-33. doi: 10.2146/ajhp070392. Review. Erratum in: Am J Health Syst Pharm. 2010 Jan 15;67(2):94.

PMID:
19386945
8.
9.

[Review of cases of prolonged QTC and wave burst arrhythmia in patients treated with methadone].

Laqueille X, Richa S, Kerbage H, Scart-Gres C, Berleur MP.

Encephale. 2012 Feb;38(1):58-63. doi: 10.1016/j.encep.2011.02.005. Epub 2011 May 25. Review. French.

PMID:
22381725
10.

Methadone-induced Torsade de pointes tachycardias.

Sticherling C, Schaer BA, Ammann P, Maeder M, Osswald S.

Swiss Med Wkly. 2005 May 14;135(19-20):282-5. Review.

PMID:
15986265
11.

[Drug induced QT prolongation].

Altmann D, Eggmann U, Ammann P.

Wien Klin Wochenschr. 2008;120(5-6):128-35. doi: 10.1007/s00508-008-0940-6. Review. German.

PMID:
18365152
12.
13.

[Methadone treatment and its dangers].

Reingardiene D, Jodziƫniene L, Lazauskas R.

Medicina (Kaunas). 2009;45(5):419-25. Review. Lithuanian.

14.

Protease inhibitor-associated QT interval prolongation.

Hunt K, Hughes CA, Hills-Nieminen C.

Ann Pharmacother. 2011 Dec;45(12):1544-50. doi: 10.1345/aph.1Q422. Epub 2011 Nov 29. Review.

PMID:
22128044
15.

Methadone: to ECG or not to ECG...That is still the question.

Cruciani RA.

J Pain Symptom Manage. 2008 Nov;36(5):545-52. doi: 10.1016/j.jpainsymman.2007.11.003. Epub 2008 Apr 28. Review.

PMID:
18440771
16.

The QT interval.

Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN.

Prog Cardiovasc Dis. 2001 Mar-Apr;43(5 Suppl 1):1-45. Review.

PMID:
11269621
17.

Probable case of torsades de pointes induced by fluconazole.

Khazan M, Mathis AS.

Pharmacotherapy. 2002 Dec;22(12):1632-7. Review.

PMID:
12495173
18.

Methadone maintenance dosing guideline for opioid dependence, a literature review.

Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.

J Addict Dis. 2010 Jan;29(1):1-14. doi: 10.1080/10550880903436010. Review.

PMID:
20390694
19.

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Haddad PM, Anderson IM.

Drugs. 2002;62(11):1649-71. Review.

PMID:
12109926
20.

Methadone death, dosage and torsade de pointes: risk-benefit policy implications.

Latowsky M.

J Psychoactive Drugs. 2006 Dec;38(4):513-9. Review.

PMID:
17373567

Supplemental Content

Support Center